Email this article Association of polymorphisms of HLA-DRB1 and TNF-308 G/A with radiographic joint damage in patients with early rheumatoid arthritis with high inflammatory activity, treated according to the principle of “Treat to target” (REMARKA study)
- Authors: Guseva IA1, Smirnov AV1, Demidova NV1, Krylov MY.1, Avdeeva AS1, Samarkina EY.1, Luchikhina EL2, Karateev DE2, Abramov DD3, Nasonov EL1,4
-
Affiliations:
- Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova»
- Moscow Regional Research and Clinical Institute (MONIKI)
- National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia
- Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 90, No 5 (2018)
- Pages: 38-43
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32740
- DOI: https://doi.org/10.26442/terarkh201890538-43
- ID: 32740
Cite item
Full Text
Abstract
Objective. To clarify the association between HLA-DRB1 and TNFα (-308G>A) genes polymorphism and joint destruction/further progression during 12 months of the follow-up period (FUP) in patients with early (<6 months), active, predominantly antibodies to cyclic citrullinated peptide (ACCP) and rheumatoid factor (RF)-positive rheumatoid arthritis (RA) treated according to "Treat to target" strategy. Materials and Methods. The study included 85 patients with early RA and duration of symptoms <6 months. All patients were initially assigned to subcutaneous methotrexate (MTX) with rapid dose escalation to 20-25 mg/week. Combination MTX + biological therapy, mainly adalimumab, was used when MTX was ineffective. Joint destruction was assessed by Sharp-Van der Heijde modification scoring method at baseline and after 12 months FUP. Real time polymerase chain reaction (PCR-RT) was used for TNFα gene polymorphism (-308G>A) genotyping. Low resolution PCR-RT with subsequent sequence-based typing of *04 were performed to study HLA-DRB1 gene polymorphism. The HLA-DRB1*01, *04:01, *04:04, *04:05, *04:08, *10 alleles were categorized as SE+ (Shared Epitope) alleles. Results. As for TNFα gene polymorphism, it was demonstrated that the number of narrowings and total Sharp score values were almost twice as high at baseline in GG genotype carriers as compared to GA genotype carriers (р<0,005, and р<0,004 respectively). Similar association was found after 12mo FUP. The progression of joint destruction, assessed as the change (∆) in the number of erosions, joint space narrowings and the total score, was statistically significantly associated with HLA-DRB1*(SE) genotypes: the carriers of SE (SE+/SE+) double-dose had more advanced progression as compared to (SE+/SE-)/(SE-/SE-) carriers (р<0,028, р<0,019, р<0,035 respectively). Conclusion. Our data suggest that HLA-DRB1 (SE+) gene and TNFα (-308G>A) polymorphisms are associated with the progression of radiographic joint destruction in early, active RA patients managed according to "Treat to target" stratagy.
Full Text
##article.viewOnOriginalSite##About the authors
I A Guseva
Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova»
Email: irrgus@yandex.ru
к.м.н., с.н.с.; ORCID ID orcid.org/0000-0002-4906-7148
A V Smirnov
Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova»д.м.н., зав. лаб.
N V Demidova
Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova»к.м.н., н.с.
M Yu Krylov
Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova»к.м.н., ст.н.с.
A S Avdeeva
Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova»к.м.н., н.с.
E Yu Samarkina
Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova»м.н.с.
E L Luchikhina
Moscow Regional Research and Clinical Institute (MONIKI)к.м.н., в.н.с.
D E Karateev
Moscow Regional Research and Clinical Institute (MONIKI)д.м.н., гл. н.с.
D D Abramov
National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russiaк.б.н., в.н.с.
E L Nasonov
Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova»; Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federationакад. РАН, научный руководитель ФГБНУ НИИР им. В.А. Насоновой
References
- Насонов Е.Л., Каратеев Д.Е., Балабанова Р.М. Ревматоидный артрит. В кн.: Ревматология. Национальное руководство. Под ред. Е.Л. Насонова, В.А. Насоновой. Москва: ГЭОТАР-Медиа, 2008: 290-331.
- Aletaha D, Neogi T, Silman A.J, Funovits J, Felson D.T, Bingham C.O 3rd, Birnbaum N.S, Burmester G.R, Bykerk V.P, Cohen M.D, Combe B, Costenbader K.H, Dougados M, Emery P, Ferraccioli G, Hazes J.M, Hobbs K, Huizinga T.W, Kavanaugh A, Kay J, Kvien T.K, Laing T, Mease P, Ménard H.A, Moreland L.W, Naden R.L, Pincus T, Smolen J.S, Stanislawska-Biernat E, Symmons D, Tak P.P, Upchurch K.S, Vencovský J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-2581. https://doi: 10.1002/art.27584
- Rojas-Villarraga A, Diaz F.J, Calvo-Páramo E, Salazar J.C, Iglesias-Gamarra A, Mantilla R.D, Anaya J.M. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis. J Autoimmun. 2009;32(1):64-69. https://doi: 10.1016/j.jaut.2008.11.004
- Knevel R, Gröndal G, Huizinga T.W, Visser A.W, Jónsson H, Víkingsson A, Geirsson A.J, Steinsson K, van der Helm-van Mil A.H. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population - based study. Ann Rheum Dis. 2012;71(5):707-709. https://doi: 10.1136/annrheumdis-2011-200627
- Kolfenbach J.R, Deane K.D, Derber L.A, O'Donnell C, Weisman M.H, Buckner J.H, Gersuk V.H, Wei S, Mikuls T.R, O'Dell J, Gregersen P.K, Keating R.M, Norris J.M, Holers V.M. A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first - degree relatives of probands with RA. Arthritis Rheum. 2009;61(12):1735-1742. https;//doi: 10.1002/art.24833.
- Ärlestig L, Mullazehi M, Kokkonen H, Rocklöv J, Rönnelid J, Dahlqvist S.R. Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden. Ann Rheum Dis. 2012;71(6):825-829. https://doi: 10.1136/annrheumdis-2011-200668
- van den Berg W.B, van Riel P.L. Uncoupling of inflammation and destruction in rheumatoid arthritis: myth or reality? Arthritis Rheum. 2005 Apr;52(4):995-9.
- Aletaha D, Alasti F, Smolen J.S. Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients. Ann Rheum Dis. 2013;72(1):7-12. https://doi: 10.1136/annrheumdis-2012-201970
- Mac Gregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1*0401/0404genotype and rheumatoid arthritis: increased association in men, young age atonset, and disease severity. J Rheumatol. 1995;22(6):1032-1036.
- Gorman J.D, Lum R.F, Chen J.J, Suarez-Almazor M.E, Thomson G, Criswell L.A. Impactof shared epitope genotype and ethnicity on erosive disease: a meta - analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum. 2004;50(2):400-412.
- Гусева И.А., Демидова Н.В., Лучихина Е.Л., Новиков А.А., Александрова Е.Н., Болдырева М.Н., Гуськова И.А., Каратеев Д.Е., Насонов Е.Л. Иммуногенетические и иммунологические маркеры раннего ревматоидного артрита (РА). Результаты первого этапа исследований по программе РАДИКАЛ. Научно - практическая ревматология. 2008; 6: 17-26
- Khanna D, Wu H, Park G, Gersuk V, Gold R.H, Nepom G.T, Wong W.K, Sharp J.T, Reed E.F, Paulus H.E, Tsao B.P; Western Consortium of Practicing Rheumatologists. Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis Rheum. 2006;54(4):1105-1116.
- van der Helm-van Mil A.H, Kurreeman F.A, Toes R.E, Huizinga T.W. Association of tumor necrosis factor alpha polymorphism and radiographic progression in rheumatoid arthritis: comment on the article by Khanna et al. Arthritis Rheum. 2007;56(3):1032-1033; author reply1033-1034.
- Reneses S, González-Escribano M.F, Fernández-Suárez A, Pestana L, Davila B, Wichmann I, García A. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor - alpha gene promoter polymorphism, rheumatoid factor, anti - citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent - onset rheumatoid arthritis. J Rheumatol. 2009;36(6):1143-1149. https://doi: 10.3899/jrheum.081075
